Ss Innovations International Inc. · NASDAQ:SSII
Ss Innovations International — Investor Presentation (January 2026)
25 slides from Ss Innovations International's investor presentation, Jan 28, 2026
Slide 1: We Build Advanced, Affordable and Accessible Surgical Robotic Solutions
We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation January 2026 Nasdaq: SSII
Slide 2: Disclaimers
Disclaimers No Offering of Securities No offer is made by this Company Presentation (this “Presentation”) to invest in SS Innovations International, Inc. (the “Company”) or to purchase any of its securities. Any offer to make such an investment or purchase and such investment or purchase will be mad
Slide 3: Our Vision
Our Vision To continuously improve and deploy our technologically- advanced, cost-effective surgical robotic systems, while maintaining affordability and accessibility for the benefit of a larger segment of patients globally © 2026 SS INNOVATIONS INTERNATIONAL, INC. 3
Slide 4: Snapshot of SS Innovations
Snapshot of SS Innovations • We develop innovative, differentiated surgical robotic technologies, highlighted by our: 7,800+ 168 Multi-Specialty Surgeries SSI Mantra Systems Installed • Proprietary surgical robotic system, “SSi Mantra 3”; • Comprehensive suite of surgical instruments, which 9 153 su
Slide 5: Snapshot of SS Innovations (Continued)
Snapshot of SS Innovations (Continued) Headquarters Gurugram, India 217 93 73 Company Domicile Florida, USA 8 Employees (October 31, 2025) 489 Year Merged with Avra Medical 2023 400 Year Uplisted to Nasdaq 2025 Ticker SSII 444 Exchange Nasdaq-CM Shares Out (10/27/25) 193.6 mm 3,409 Recent Price (1/7
Slide 6: Investment Highlights
Investment Highlights 1• Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology 2• Large and Growing Total Addressable Market with Favorable Industry Tailwinds 3• Advanced, Cost-Efficient Surgical Robotics Platform – Clinically and Commercially Differentiated 4•
Slide 7: Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology
Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology Sudhir Srivastava, MD, Founder, Chairman & CEO Tim Paul Adams, Board Member • Robotic cardiac surgeon with 40+ years of experience • Regional Operating Officer, Ascension • Pioneered many of the world’s first
Slide 8: Accelerated Global Adoption of Robotic Surgery
Large and Growing Addressable Market with Favorable Industry Tailwinds Accelerated Global Adoption of Robotic Surgery Key Market Trends Global Surgical Robotics Market (in USD billions)1 Innovation and enhanced capabilities make next-generation systems Technology versatile across a broad spectrum of
Slide 9: Access to Robotic Surgery Remains Limited
Large and Growing Addressable Market with Favorable Industry Tailwinds Access to Robotic Surgery Remains Limited Benefits of Robotic Surgery Reduced Smaller Greater Minimal Blood Faster 10x Magnified Less Pain and Reduced Risk Surgeon Incisions on Precision Loss Recovery 3D vision Discomfort of Infe
Slide 10: Unmet Needs and Market Opportunity Support Our Foundational Market in India
Large and Growing Addressable Market with Favorable Industry Tailwinds Unmet Needs and Market Opportunity Support Our Foundational Market in India 1.5 Hospital Beds Estimated need of 5,000 ~1.4 Billion ~70,000 per 1,000 people surgeries per year per Population Hospitals (compared to the 100,000 peop
Slide 11: SSi Mantra 3
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 2 2 Patient-Side Robotic Arm Carts 3 Vision Cart 3 Modular robotic arms mounted on individual carts with the option of 3D 4K resolution monitor, identical using 3, 4 or 5 robotic arm to the surgeon’s console, for OR configurations staf
Slide 12: SSi Mantra 3 – Surgical Command Center
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Surgical Command Center Ergonomic Open-Faced Large 3D 4K Monitor Console Large 2D Touch Monitor Lightweight Magnetic for System Controls and Hand Controls Design DICOM access Head Tracking Digital Ergonomics Safety Feature Control Te
Slide 13: SSi Mantra 3 – Patient Side Robotic Arm Carts
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Patient Side Robotic Arm Carts Modular Freedom of Robotic Carts Patient Docking 3/4/5 Absolute Stability Patient Cart Parking Locks Connectivity Smaller Individual Advanced Touch Cart Footprint Screen Controls © 2026 SS INNOVATIONS I
Slide 14: SSi Mudra – Multi Specialty Robotic Instruments
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mudra – Multi Specialty Robotic Instruments 20+ 1 40+ 10 Use 1 7 Degrees of Freedom Cardiac Specialty Instruments Types of Articulating Robotic Life Cycle Only company in the world actively advocating for robotic cardiac surgery Instruments Ins
Slide 15: SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies
Advanced, Cost-Efficient Surgical Robotics Platform SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies SSi Guru AR Smart Glasses1 Cognitive Skill Simulator1 XR Tele Proctoring System 3D Visualization System A different approach to train surgeons • Mixed Reality
Slide 16: Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit
Advanced, Cost-Efficient Surgical Robotics Platform Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit 120+ telesurgeries have been completed with the SSi Mantra surgical robotic system2 Feb 2025 SSII HQ Manipal Hospital 177 miles Gurugram, India Jaipur, India Mar 2025 SSII HQ A
Slide 17: The SSi Mantra Tele Surgeon Console Facilitates Telesurgery from Anywhere
Advanced, Cost-Efficient Surgical Robotics Platform The SSi Mantra Tele Surgeon Console Facilitates Telesurgery from “Anywhere” SSi Mantra Tele Surgeon Console (the “TSC”) Compact Self- Contained Chair Enables Portability Inbuilt Electronics Requires Less Space Magnetic Sensor- Based Controls Facili
Slide 18: World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency
Established Presence in India with Global Expansion Underway World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency Proximity to R&D, Manufacturing, New Delhi Assembly, and Operations International airport in Gurgaon, Delhi with excellent National Capital Region connectiv
Slide 19: SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies
Established Presence in India with Global Expansion Underway SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies Overview of Installed Base Cumulative Installed Base +158% 168 65 As of 12/31/24 As of 12/31/25 Completed Procedures +186% 7,885 2,759 As of 12/31/24 As of 12/31/25 In
Slide 20: Global Expansion - Quality and Regulatory Approvals
Established Presence in India with Global Expansion Underway Global Expansion - Quality and Regulatory Approvals India CDSCO EN ISO 13485 Guatemala Chile 2023 2021 2023 No Approval Required Nepal Indonesia Sri Lanka Ecuador No Approval Required 2024 2024 2024 Philippines Ukraine Colombia Oman 2025 2
Slide 21: Estimated Regulatory Timelines
Established Presence in India with Global Expansion Underway Estimated Regulatory Timelines Current Stage US FDA FDA Q Sub Regulatory Strategy 510(k) 510(k) Submitted for FDA Review / Feedback, Biocompatibility, Technical dossier Multi-Specialty Indications Market Clearance Reprocessing preparation1
Slide 22: Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins
Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins Revenue Revenue Mix Gross Margin ($ millions) (%) (%) +1,134 bps +108% +2,858 bps 47.11% $43.0 40.93% 35.77% +251% $43.0 mm 15% 85% Revenue $20.6 2025* 12.35% $5.9 2023 2024 *2025 2023 2024 9M '24 9M '2
Slide 23: Growth Strategy
Growth Strategy Target Leading Surgeons and Thought Platform Focus on Large Leaders to Raise Awareness and Value Multi-Specialty Hospitals Encourage Widespread Adoption • Advanced Technology • Secure Initial Placements • Indian Medical Advisory Board • Lower Cost • Expand # of Physicians using Mantr
Slide 24: FY 2024 – FY 2025 YTD Financial Summary and 2025 Preliminary Estimated Unaudited Revenue
FY 2024 – FY 2025 YTD Financial Summary and 2025 Preliminary Estimated Unaudited Revenue SS Innovations Twelve Months Ended Nine Months Ended Three Months Ended Statement of Operations (in USD) Dec. 31, 2023 Dec. 31, 2024 Dec. 31, 20251 Sept. 30, 2024 Sept. 30, 2025 Sept. 30, 2024 Sept. 30, 2025 Rev
Slide 25: Investor Contact
Investor Contact: Kalle Ahl, CFA (303) 953-9878 kahl@theequitygroup.com www.ssinnovations.com investors@ssinnovations.org © 2026 SS INNOVATIONS INTERNATIONAL, INC. 25
SS Innovations International — Investor Presentation (January 2026) on 6ix